Rintatolimod in Advanced Pancreatic Cancer Enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses

0
28
Investigators studied the effect of TLR-3 activation through rintatolimod on the peripheral immune landscape of advanced PDAC patients.
[Clinical Cancer Research]
Abstract